Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2003
12/03/2003EP0852140B1 Methods for making hardly soluble medicine amorphous
12/03/2003EP0767666B1 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
12/03/2003EP0727982B1 Propylene glycol stearate vesicles
12/03/2003EP0711158B1 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent
12/03/2003CN1460111A HIV peptides from conserved regions in GAGP 17 and 924 and their application in e.g. vaccines
12/03/2003CN1460100A Compounds and compositions for delivering active agents
12/03/2003CN1460026A Compositions containing alpha-2-adrenergic agonist components
12/03/2003CN1460021A Plaster preparation
12/03/2003CN1460019A Improved injectable dispersions of propofol
12/03/2003CN1460018A Implantable gel compositions and method of mfg.
12/03/2003CN1460013A 局部凝胶给药体系 Topical gel delivery system
12/03/2003CN1459334A Method for producing plant ultra-micropowder
12/03/2003CN1459316A Plant substrates
12/03/2003CN1459313A Prepared Chinese medicine for treating various kinds of face spots
12/03/2003CN1459307A Fragrance chewing gum for preventing from tooth-decay
12/03/2003CN1459303A Kudzu vine flavone capsule, and its prepn. method
12/03/2003CN1459302A Kudzu vine flavone capsule, and its prepn. method
12/03/2003CN1459287A Cytophosphocholine sodium quantitative drop
12/03/2003CN1459286A Tetrodotoxin respiratory tract administration prepn. used for giving-up drug and easing pain
12/03/2003CN1459285A Plaster for reunion of laceration of skin
12/03/2003CN1459284A Neohouttuynin sodium freeze-dried powder-injection, and its prepn. method
12/03/2003CN1129448C Chinese medicine pills for treating cataract
12/03/2003CN1129438C Bone strengthening and pus drawing out ointment
12/03/2003CN1129429C Potassium sodium and tris oxaprozin salt pharmaceutical formulations
12/03/2003CN1129427C TTS contg. antioxidant
12/03/2003CN1129426C Percutaneous absorption type preparation
12/03/2003CN1129425C Medicated tissue paper product
12/03/2003CN1129424C Ceramide lipsome emulsion contaniing Va and its preparing process and usage
12/03/2003CN1129423C Novel laxative compositions and its preparing method
12/03/2003CN1129418C Method of producing lenticular tablets and calender moulding roll therefor
12/03/2003CA2409795A1 Liposome preparation
12/02/2003US6656984 Hydrophobic polymer dispersion and process for the preparation thereof
12/02/2003US6656936 Growth inhibitors of Candida albicans, and anti-HIV agents
12/02/2003US6656929 Pharmaceutical composition with a synthetic natural progesterone and oestradiol base and its preparation process
12/02/2003US6656920 Administering a disaccharide such as maltose or trehalose, optionally along with Vitamin C or a derivative, to increase saliva excretion; treating Sjogren's syndrome and xerostomia
12/02/2003US6656734 Compositions for the delivery of polynucleotides to cells
12/02/2003US6656679 Heat shock protein-based vaccines and immunotherapies
12/02/2003US6656508 Sustained-release alginate gels
12/02/2003US6656507 Aqueous dispersion suitable for the production of coatings and binders for solid oral drugs
12/02/2003US6656506 Microparticle coated medical device
12/02/2003US6656505 Method for forming an aqueous flocculated suspension
12/02/2003US6656504 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
12/02/2003US6656503 Counters ulcerogenic side effects; nonsteroidal antiinflam-matory core with polymer and misoprostol coating
12/02/2003US6656502 Sustained-release prostaglandin I derivative preparation
12/02/2003US6656501 Easy to swallow capsule containing filler to reduce buoyancy
12/02/2003US6656500 For delivery of water insoluble active retinoid agents comprising a vehicle for initially dissolving the active agent, emulsifier and capsule shell formulated to open in the gastrointestinal tract
12/02/2003US6656499 Composition for transdermal and dermal administration of interferon-α
12/02/2003US6656498 Cationic liposomes for gene transfer
12/02/2003US6656497 Liposomal vector for active-principle
12/02/2003US6656493 Edible film formulations containing maltodextrin
12/02/2003US6656492 Quick disintegrating tablet in buccal cavity and manufacturing method thereof
12/02/2003US6656491 High rate of release; skin compatibility coupled with good adhesion; thermoplastic resin and spun fiber self-adhesive
12/02/2003US6656485 Salified, water soluble bark extract; antiseptic properties
12/02/2003US6656482 Spill resistant pharmaceutical system
12/02/2003US6656481 Vaccinal preparations
12/02/2003US6656473 Defatted meal from squash seeds containing protein-bound tryptophan and carbohydrate source (glucose, maltose, sucrose) for facilitating transport across the blood brain barrier; useful for inducing sleep
12/02/2003US6656470 Vaccine composition, method of preparing the same, and method of vaccinating vertebrates
12/02/2003US6656460 Method and composition for dry eye treatment
12/02/2003US6656453 Aerosol formulation comprising particulate salbutamol sulphate having a crystalline form in which the outer layer of the crystals is nonamorphous and 1,1,1,2-tetrafluoroethane; for treating respiratory disorders
12/02/2003US6656452 Use of inhaled NO as anti-inflammatory agent
12/02/2003US6656385 Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
12/02/2003US6656172 Method for treating severe tinnitus
12/02/2003US6656162 Implantable drug delivery stents
12/02/2003US6655379 Aerosolized active agent delivery
12/02/2003CA2266484C Tablets containing a sweetening mixture
12/02/2003CA2132865C Transdermal administration of oxybutynin
12/02/2003CA2113901C Preparation of microparticles
12/02/2003CA2075201C Use of an .alpha.-tocopherol phosphate or a derivative thereof for preparing cosmetic, dermatological or pharmaceutical compositions, and compositions thereby obtained
11/2003
11/27/2003WO2003097805A2 Delivery of nucleic acid-like compounds
11/27/2003WO2003097696A1 Methods and copositions for the treatment of ischemic reperfusion
11/27/2003WO2003097672A1 Method for controlling protein
11/27/2003WO2003097140A1 Drug delivery assembly
11/27/2003WO2003097109A1 Improvements in delivery technology
11/27/2003WO2003097103A1 Quickly soluble film preparations
11/27/2003WO2003097102A1 Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water
11/27/2003WO2003097101A1 Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity
11/27/2003WO2003097100A1 Topical composition for the treatment of inflammatory conditions of the skin
11/27/2003WO2003097094A1 Method of prophylaxis of infection
11/27/2003WO2003097083A1 Medicinal compositions containing ghrelin
11/27/2003WO2003097073A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
11/27/2003WO2003097061A1 External preparation for allergic diseases
11/27/2003WO2003097058A1 New pharmaceutical compositions containing flibanserin polymorph a
11/27/2003WO2003097054A1 Compositions and method for treating infection in cattle and swine
11/27/2003WO2003097039A1 Stable dosage forms comprising atorvastatin calcium
11/27/2003WO2003097027A1 OIL-IN-WATER EMULSION OF l-MENTHOL
11/27/2003WO2003097026A1 Smooth muscle peristole inhibitor
11/27/2003WO2003097025A2 A process for preparing pharmaceutical compositions containing 4-aminoquinolines compounds for treatment of inflammatory disorders of the eye and compositions resulting therefrom
11/27/2003WO2003097022A1 Matrix type patch containing bronchodilators
11/27/2003WO2003097021A2 Use of transdermal topical systems for the prevention and treatment of primary dysmenorrhea
11/27/2003WO2003097020A1 Transdermal delivery system with two superimposed adhesive layers having different affinities to the active substance comprised
11/27/2003WO2003097019A1 Multilamellar system for the administration of active agents by means of ingestion
11/27/2003WO2003097018A1 Hydrodynamically balancing oral drug delivery system with biphasic release
11/27/2003WO2003097017A1 Use of completely linear short chain alpha-glucans as a pharmaceutical excipient
11/27/2003WO2003097016A1 Agent delivery system
11/27/2003WO2003097015A1 Short chain polymer for enhancing the bioadhesiveness of polymers on mucosal membrane
11/27/2003WO2003097013A1 Mono-coating for powdered pharmaceuticals
11/27/2003WO2003097012A1 Co-grinding process for the preparation of a ternary composition
11/27/2003WO2003097011A1 Compositions and methods using proton pump inhibitors
11/27/2003WO2003097010A1 Medicinal preparation in a colloid for topical application in the therapy and prophylaxis of states of pain and itching
11/27/2003WO2003097009A1 Injection formulation
1 ... 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 ... 2991